Form 4: Macrogenics Director William K. Heiden Acquires Stock Options and Restricted Stock Units

Director William K. Heiden reports acquisition of stock options and restricted stock units in Macrogenics Inc.

Summary

• On May 21, 2024, William K. Heiden, a director of Macrogenics Inc. (MGNX), acquired 16,500 stock options with an exercise price of $4.26, expiring on May 21, 2034.
• He also acquired 6,500 restricted stock units (RSUs), each representing a contingent right to receive one share of Macrogenics' common stock.
• The RSUs will vest one year after the grant date or the day before the next annual meeting, whichever is earlier.
• The stock options will vest and become exercisable in monthly increments over one year from the grant date.

Sentiment

Score: 5

Explanation: Neutral sentiment as it's a standard disclosure of insider transactions.

Positives

• The acquisition of stock options and RSUs by a director may indicate confidence in the company's future performance.

Industry Context

Form 4 filings are standard disclosures required by the SEC to provide transparency regarding the transactions of company insiders.

Stakeholder Impact

• Shareholders are informed about the transactions of a company director.
• Employees may be indirectly affected by the perceived confidence in the company reflected by the director's actions.

Key Dates